Symbols / CARL Stock $9.53 -3.40% Carlsmed, Inc.
CARL (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Ratings
Current target
$9.53
Low
$17.00
High
$23.00
Mean
$18.60
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-15 | main | Truist Securities | Buy → Buy | $18 |
| 2026-04-09 | main | Goldman Sachs | Buy → Buy | $17 |
| 2025-12-15 | reit | BTIG | Buy → Buy | $24 |
| 2025-11-07 | reit | Truist Securities | Buy → Buy | $20 |
| 2025-11-07 | main | BTIG | Buy → Buy | $24 |
| 2025-08-18 | init | Truist Securities | — → Buy | $18 |
| 2025-08-18 | init | Goldman Sachs | — → Buy | $19 |
| 2025-08-18 | init | Piper Sandler | — → Overweight | $18 |
- symbol__ Stock Quote Price and Forecast - CNN Wed, 16 Jul 2025 19
- Carlsmed (CARL) Analyst Rating: Goldman Sachs Lowers Price Targe - GuruFocus hu, 09 Apr 2026 20
- Carlsmed, Inc. (NASDAQ:CARL) Short Interest Up 23.4% in March - MarketBeat hu, 16 Apr 2026 07
- CARL Stock Price and Chart — NASDAQ:CARL - TradingView ue, 22 Jul 2025 07
- Carlsmed (CARL) Stock: Why Market Expansion (Slight Loss) 2026-04-16 - Trending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La hu, 16 Apr 2026 21
- Carl Zeiss Meditec AG's (ETR:AFX) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance Sun, 21 Sep 2025 07
- Carlsmed Stock: Back To Where We Started (NASDAQ:CARL) - Seeking Alpha Sat, 29 Nov 2025 08
- Workday stock drops 5%+ after CEO Carl Eschenbach steps down - SiliconANGLE Mon, 09 Feb 2026 08
- Carlsbad-based medical technology company begins trading on Nasdaq - fox5sandiego.com Wed, 23 Jul 2025 07
- Who Is Carl Icahn? - The Motley Fool hu, 11 Sep 2025 07
- CARL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI Sat, 04 Apr 2026 13
- Carlsmed (NASDAQ:CARL) Price Target Cut to $18.00 by Analysts at Truist Financial - MarketBeat Wed, 15 Apr 2026 07
- Carl Zeiss Meditec (ETR:AFX) shareholders have endured a 62% loss from investing in the stock three years ago - Yahoo Finance Sun, 20 Jul 2025 07
- Carlsmed: Spine Play Does Not Have My Backing Yet (NASDAQ:CARL) - Seeking Alpha hu, 24 Jul 2025 07
- Legendary Investor Carl Icahn Is Betting Big on Monro Stock. Should You Buy MNRO Here? - Yahoo Finance Wed, 05 Nov 2025 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Revenue |
|
50.51
+85.94%
|
27.16
+97.16%
|
13.78
|
| Operating Revenue |
|
50.51
+85.94%
|
27.16
+97.16%
|
13.78
|
| Cost Of Revenue |
|
12.47
+75.23%
|
7.12
+83.66%
|
3.88
|
| Reconciled Cost Of Revenue |
|
12.47
+75.23%
|
7.12
+83.66%
|
3.88
|
| Gross Profit |
|
38.04
+89.74%
|
20.05
+102.44%
|
9.90
|
| Operating Expense |
|
68.61
+55.34%
|
44.17
+55.02%
|
28.49
|
| Research And Development |
|
17.02
+18.98%
|
14.30
+93.43%
|
7.39
|
| Selling General And Administration |
|
51.59
+72.75%
|
29.87
+41.55%
|
21.10
|
| Selling And Marketing Expense |
|
35.03
+63.13%
|
21.47
+42.19%
|
15.10
|
| General And Administrative Expense |
|
16.57
+97.38%
|
8.39
+39.95%
|
6.00
|
| Other Gand A |
|
16.57
+97.38%
|
8.39
+39.95%
|
6.00
|
| Total Expenses |
|
81.08
+58.10%
|
51.29
+58.44%
|
32.37
|
| Operating Income |
|
-30.57
-26.75%
|
-24.12
-29.75%
|
-18.59
|
| Total Operating Income As Reported |
|
-30.57
-26.75%
|
-24.12
-29.75%
|
-18.59
|
| EBITDA |
|
-27.92
-22.52%
|
-22.79
-25.77%
|
-18.12
|
| Normalized EBITDA |
|
-27.59
-21.85%
|
-22.65
-24.98%
|
-18.12
|
| Reconciled Depreciation |
|
0.28
+93.79%
|
0.14
+6.62%
|
0.14
|
| EBIT |
|
-28.20
-22.97%
|
-22.94
-25.63%
|
-18.26
|
| Total Unusual Items |
|
-0.33
-127.78%
|
-0.14
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-0.33
-127.78%
|
-0.14
|
—
|
| Net Income |
|
-29.63
-22.17%
|
-24.26
-28.36%
|
-18.90
|
| Pretax Income |
|
-29.63
-22.17%
|
-24.26
-28.36%
|
-18.90
|
| Net Non Operating Interest Income Expense |
|
1.27
+13988.89%
|
0.01
+102.93%
|
-0.31
|
| Interest Expense Non Operating |
|
1.43
+8.25%
|
1.32
+106.08%
|
0.64
|
| Net Interest Income |
|
1.27
+13988.89%
|
0.01
+102.93%
|
-0.31
|
| Interest Expense |
|
1.43
+8.25%
|
1.32
+106.08%
|
0.64
|
| Interest Income Non Operating |
|
2.70
+102.86%
|
1.33
+298.20%
|
0.33
|
| Interest Income |
|
2.70
+102.86%
|
1.33
+298.20%
|
0.33
|
| Other Income Expense |
|
-0.33
-127.78%
|
-0.14
|
—
|
| Gain On Sale Of Security |
|
-0.33
-127.78%
|
-0.14
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-29.63
-22.17%
|
-24.26
-28.36%
|
-18.90
|
| Net Income From Continuing Operation Net Minority Interest |
|
-29.63
-22.17%
|
-24.26
-28.36%
|
-18.90
|
| Net Income From Continuing And Discontinued Operation |
|
-29.63
-22.17%
|
-24.26
-28.36%
|
-18.90
|
| Net Income Continuous Operations |
|
-29.63
-22.17%
|
-24.26
-28.36%
|
-18.90
|
| Normalized Income |
|
-29.31
-21.54%
|
-24.11
-27.60%
|
-18.90
|
| Net Income Common Stockholders |
|
-30.22
-21.61%
|
-24.85
-31.49%
|
-18.90
|
| Diluted EPS |
|
-2.12
+65.31%
|
-6.11
-43.75%
|
-4.25
|
| Basic EPS |
|
-2.12
+65.30%
|
-6.11
-43.73%
|
-4.25
|
| Basic Average Shares |
|
14.22
+249.74%
|
4.07
-8.53%
|
4.45
|
| Diluted Average Shares |
|
14.22
+249.74%
|
4.07
-8.53%
|
4.45
|
| Diluted NI Availto Com Stockholders |
|
-30.22
-21.61%
|
-24.85
-31.49%
|
-18.90
|
| Preferred Stock Dividends |
|
0.58
-1.35%
|
0.59
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Assets |
|
130.12
+151.08%
|
51.82
+269.54%
|
14.02
|
| Current Assets |
|
126.67
+156.68%
|
49.35
+319.47%
|
11.77
|
| Cash Cash Equivalents And Short Term Investments |
|
109.79
+173.63%
|
40.12
+455.59%
|
7.22
|
| Cash And Cash Equivalents |
|
85.79
+113.81%
|
40.12
+455.59%
|
7.22
|
| Other Short Term Investments |
|
24.00
|
0.00
|
—
|
| Receivables |
|
11.36
+67.93%
|
6.77
+113.78%
|
3.17
|
| Accounts Receivable |
|
11.36
+67.93%
|
6.77
+113.78%
|
3.17
|
| Gross Accounts Receivable |
|
13.02
+62.59%
|
8.01
+98.34%
|
4.04
|
| Allowance For Doubtful Accounts Receivable |
|
-1.65
-33.41%
|
-1.24
-42.25%
|
-0.87
|
| Inventory |
|
1.84
+85.43%
|
0.99
+73.04%
|
0.57
|
| Work In Process |
|
0.06
-85.75%
|
0.40
+33.78%
|
0.30
|
| Finished Goods |
|
1.79
+200.50%
|
0.59
+115.58%
|
0.28
|
| Restricted Cash |
|
0.10
+0.00%
|
0.10
-33.33%
|
0.15
|
| Other Current Assets |
|
3.57
+161.76%
|
1.36
+109.04%
|
0.65
|
| Total Non Current Assets |
|
3.45
+39.39%
|
2.47
+9.47%
|
2.26
|
| Net PPE |
|
3.31
+74.00%
|
1.90
-15.15%
|
2.24
|
| Gross PPE |
|
3.84
+66.70%
|
2.30
-7.81%
|
2.50
|
| Accumulated Depreciation |
|
-0.53
-31.83%
|
-0.40
-57.09%
|
-0.25
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.13
+95.85%
|
0.58
+45.11%
|
0.40
|
| Construction In Progress |
|
0.52
|
0.00
|
—
|
| Other Properties |
|
1.83
+11.07%
|
1.64
-18.57%
|
2.02
|
| Leases |
|
0.35
+343.75%
|
0.08
+0.00%
|
0.08
|
| Other Non Current Assets |
|
0.13
-76.45%
|
0.57
+3693.33%
|
0.01
|
| Total Liabilities Net Minority Interest |
|
31.25
-74.48%
|
122.45
+103.57%
|
60.15
|
| Current Liabilities |
|
14.28
+61.94%
|
8.82
+18.52%
|
7.44
|
| Payables And Accrued Expenses |
|
7.70
+54.36%
|
4.99
+62.92%
|
3.06
|
| Payables |
|
4.48
+85.78%
|
2.41
+42.38%
|
1.69
|
| Accounts Payable |
|
4.48
+85.78%
|
2.41
+42.38%
|
1.69
|
| Current Accrued Expenses |
|
3.22
+24.93%
|
2.58
+88.37%
|
1.37
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
5.83
+72.38%
|
3.38
+51.59%
|
2.23
|
| Current Debt And Capital Lease Obligation |
|
0.75
+67.48%
|
0.45
-79.10%
|
2.15
|
| Current Debt |
|
—
|
—
|
1.84
|
| Other Current Borrowings |
|
—
|
—
|
1.84
|
| Current Capital Lease Obligation |
|
0.75
+67.48%
|
0.45
+44.84%
|
0.31
|
| Total Non Current Liabilities Net Minority Interest |
|
16.97
-85.07%
|
113.64
+115.57%
|
52.71
|
| Long Term Debt And Capital Lease Obligation |
|
16.66
-0.41%
|
16.73
+81.09%
|
9.24
|
| Long Term Debt |
|
15.35
-0.44%
|
15.41
+106.26%
|
7.47
|
| Long Term Capital Lease Obligation |
|
1.32
-0.08%
|
1.32
-25.42%
|
1.77
|
| Other Non Current Liabilities |
|
0.31
+39.19%
|
0.22
+131.25%
|
0.10
|
| Preferred Securities Outside Stock Equity |
|
0.00
-100.00%
|
96.23
+121.83%
|
43.38
|
| Stockholders Equity |
|
98.87
+239.98%
|
-70.63
-53.11%
|
-46.13
|
| Common Stock Equity |
|
98.87
+239.98%
|
-70.63
-53.11%
|
-46.13
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
—
|
| Share Issued |
|
26.66
+0.56%
|
26.52
+0.00%
|
26.52
|
| Ordinary Shares Number |
|
26.66
+0.56%
|
26.52
+0.00%
|
26.52
|
| Additional Paid In Capital |
|
199.67
+36808.32%
|
0.54
-30.99%
|
0.78
|
| Retained Earnings |
|
-100.81
-41.64%
|
-71.17
-51.71%
|
-46.91
|
| Total Equity Gross Minority Interest |
|
98.87
+239.98%
|
-70.63
-53.11%
|
-46.13
|
| Total Capitalization |
|
114.22
+306.85%
|
-55.22
-42.84%
|
-38.66
|
| Working Capital |
|
112.39
+177.29%
|
40.53
+837.18%
|
4.33
|
| Invested Capital |
|
114.22
+306.85%
|
-55.22
-49.97%
|
-36.82
|
| Total Debt |
|
17.41
+1.36%
|
17.18
+50.87%
|
11.39
|
| Net Debt |
|
—
|
—
|
2.09
|
| Capital Lease Obligations |
|
2.07
+17.10%
|
1.77
-14.93%
|
2.08
|
| Net Tangible Assets |
|
98.87
+239.98%
|
-70.63
-53.11%
|
-46.13
|
| Tangible Book Value |
|
98.87
+239.98%
|
-70.63
-53.11%
|
-46.13
|
| Derivative Product Liabilities |
|
0.00
-100.00%
|
0.46
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
-28.98
-13.79%
|
-25.47
-45.69%
|
-17.48
|
| Cash Flow From Continuing Operating Activities |
|
-28.98
-13.79%
|
-25.47
-45.69%
|
-17.48
|
| Net Income From Continuing Operations |
|
-29.63
-22.17%
|
-24.26
-28.36%
|
-18.90
|
| Depreciation Amortization Depletion |
|
0.28
+93.79%
|
0.14
+6.62%
|
0.14
|
| Depreciation And Amortization |
|
0.28
+93.79%
|
0.14
+6.62%
|
0.14
|
| Other Non Cash Items |
|
0.76
+30.64%
|
0.58
+5.83%
|
0.55
|
| Stock Based Compensation |
|
1.93
+661.66%
|
0.25
+120.00%
|
0.12
|
| Provisionand Write Offof Assets |
|
0.41
+12.50%
|
0.37
-57.75%
|
0.87
|
| Asset Impairment Charge |
|
1.84
+33.45%
|
1.38
+115.31%
|
0.64
|
| Operating Gains Losses |
|
0.33
+127.78%
|
0.14
|
—
|
| Gain Loss On Investment Securities |
|
0.33
+127.78%
|
0.14
|
—
|
| Change In Working Capital |
|
-4.89
-19.94%
|
-4.08
-356.66%
|
-0.89
|
| Change In Receivables |
|
-5.01
-26.23%
|
-3.97
-63.27%
|
-2.43
|
| Changes In Account Receivables |
|
-5.01
-26.23%
|
-3.97
-63.27%
|
-2.43
|
| Change In Inventory |
|
-2.69
-49.56%
|
-1.80
-96.72%
|
-0.91
|
| Change In Prepaid Assets |
|
-2.34
-225.28%
|
-0.72
-462.50%
|
-0.13
|
| Change In Payables And Accrued Expense |
|
5.44
+100.07%
|
2.72
-13.35%
|
3.14
|
| Change In Accrued Expense |
|
3.12
+28.70%
|
2.42
+10.34%
|
2.19
|
| Change In Payable |
|
2.32
+682.15%
|
0.30
-68.50%
|
0.94
|
| Change In Account Payable |
|
2.32
+682.15%
|
0.30
-68.50%
|
0.94
|
| Change In Other Current Liabilities |
|
-0.29
+6.45%
|
-0.31
+44.44%
|
-0.56
|
| Investing Cash Flow |
|
-25.48
-14057.22%
|
-0.18
-33.33%
|
-0.14
|
| Cash Flow From Continuing Investing Activities |
|
-25.48
-14057.22%
|
-0.18
-33.33%
|
-0.14
|
| Net PPE Purchase And Sale |
|
-0.64
-256.67%
|
-0.18
-33.33%
|
-0.14
|
| Purchase Of PPE |
|
-0.64
-256.67%
|
-0.18
-33.33%
|
-0.14
|
| Capital Expenditure |
|
-1.36
-653.89%
|
-0.18
-33.33%
|
-0.14
|
| Capital Expenditure Reported |
|
-0.71
|
0.00
|
—
|
| Net Investment Purchase And Sale |
|
-24.00
|
0.00
|
—
|
| Purchase Of Investment |
|
-24.00
|
0.00
|
—
|
| Net Other Investing Changes |
|
-0.13
|
—
|
—
|
| Financing Cash Flow |
|
100.13
+71.16%
|
58.50
+1739.59%
|
3.18
|
| Cash Flow From Continuing Financing Activities |
|
100.13
+71.16%
|
58.50
+1739.59%
|
3.18
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
6.21
+98.72%
|
3.12
|
| Issuance Of Debt |
|
0.00
-100.00%
|
6.21
+98.72%
|
3.12
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
6.21
+98.72%
|
3.12
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
6.21
+98.72%
|
3.12
|
| Net Common Stock Issuance |
|
93.47
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
0.20
+502.94%
|
0.03
-38.18%
|
0.06
|
| Net Other Financing Charges |
|
-5.46
|
—
|
—
|
| Changes In Cash |
|
45.67
+39.01%
|
32.85
+327.59%
|
-14.44
|
| Beginning Cash Position |
|
40.23
+445.65%
|
7.37
-66.19%
|
21.81
|
| End Cash Position |
|
85.89
+113.53%
|
40.23
+445.65%
|
7.37
|
| Free Cash Flow |
|
-30.33
-18.28%
|
-25.65
-45.59%
|
-17.61
|
| Interest Paid Supplemental Data |
|
1.20
+7.44%
|
1.11
+116.50%
|
0.52
|
| Common Stock Issuance |
|
93.47
|
0.00
|
—
|
| Issuance Of Capital Stock |
|
105.38
+101.67%
|
52.26
|
0.00
|
| Net Preferred Stock Issuance |
|
11.92
-77.19%
|
52.26
|
0.00
|
| Preferred Stock Issuance |
|
11.92
-77.19%
|
52.26
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-04 View
- 10-K2026-02-25 View
- 8-K2026-02-25 View
- 42026-01-30 View
- 42026-01-30 View
- 42026-01-30 View
- 42026-01-30 View
- 8-K2026-01-12 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
- 8-K2025-10-30 View
- 10-Q2025-08-28 View
- 8-K2025-08-28 View
- 42025-07-24 View
- 42025-07-24 View
- 42025-07-24 View
- 42025-07-24 View
- 42025-07-24 View
- 42025-07-24 View
- 42025-07-24 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|